Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma 27Burkitt Lymphoma 27Lymphoma, Non-Hodgkin 22Lymphoma, Large B-Cell, Diffuse 22Myelodysplastic Syndromes 20Leukemia, Myeloid, Chronic-Phase 20Lymphoma, Follicular 19Leukemia, Lymphocytic, Chronic, B-Cell 18Leukemia, Myeloid, Accelerated Phase 17Multiple Myeloma 16Lymphoma, Large-Cell, Immunoblastic 15Blast Crisis 15Myeloproliferative Disorders 14Leukemia, Myeloid, Acute 14Dendritic Cell Sarcoma, Interdigitating 14Recurrence 13Lymphoma, Mantle-Cell 13Lymphoma, B-Cell, Marginal Zone 13Graft vs Host Disease 13Leukemia, Myelomonocytic, Chronic 12Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 12Hodgkin Disease 11Congenital Abnormalities 11Neoplasms, Plasma Cell 10Myelodysplastic-Myeloproliferative Diseases 10Anemia, Refractory, with Excess of Blasts 9Primary Myelofibrosis 8Lymphoma, Large-Cell, Anaplastic 8

Interventions

Cyclophosphamide 16fludarabine phosphate 12fludarabine 11Tacrolimus 11Whole-Body Irradiation 10Mycophenolic Acid 9Melphalan 9Busulfan 9Peripheral Blood Stem Cell Transplantation 7Alemtuzumab 7Methotrexate 5Cyclosporine 5Stem Cell Transplantation 4thymoglobulin 2sargramostim 2Hematopoietic Stem Cell Transplantation 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Antilymphocyte Serum 2visilizumab 1nicotinamide-beta-riboside 1methanesulfonic acid 1merphos 1X-Rays 1Transplantation 1Thiotepa 1Teriparatide 1Specimen Handling 1Sirolimus 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anemia, Aplastic × Methylprednisolone × Clear all
NCT00053989 2020-02-10

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Roswell Park Cancer Institute

Phase 2 Completed
41 enrolled 13 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Anemia, Aplastic, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Fanconi Anemia, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell, Marginal Zone, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡